XCUR EXICURE, INC.

NEUTRAL Impact: 3/10 8-K
Horizon days Filed Jun 1, 2026 Processed 4d 1h ago SEC 0001698530-26-000060
8-K context-dependent: Items 7.01
Latest settled — T+1d ⚠ clustered
XCUR ▼ -6.61% at T+1d
NEUTRAL call ✗ call lost -6.61% · α vs SPY -6.75% · entry $3.33 → $3.11
Next anchor: T+5d in 3d
Currently $2.92 · -12.31% from $3.33 entry
Entry anchored
Jun 1, 03:28 PM ET
via Databento tick
T+1d
-6.61%
call -6.61% · α -6.75%
$3.11
settled 3d ago
T+5d
call — · α —
in 3d
T+20d
call — · α —
in 25d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Exicure disclosed it received a Nasdaq delinquency notice on May 28, 2026 for late filing of its Q1 2026 10-Q, but filed the 10-Q on May 29, 2026 and believes it has regained compliance. The delay was attributed to changes in financial reporting personnel. This is a routine administrative catch-up event with no material financial impact.

Actionable Insight

The delinquency notice was resolved within 24 hours by filing the overdue 10-Q, making this a non-event for trading. Monitor future filings for any recurring delays that could signal deeper accounting or liquidity issues.

Key Facts

  • Received Nasdaq delinquency notice on May 28, 2026 for delayed Q1 2026 10-Q filing
  • Filed the Q1 2026 10-Q on May 29, 2026, one day after the notice
  • Company believes it has regained compliance with Nasdaq Listing Rule 5250(c)(1)
  • Delay attributed to changes in financial reporting personnel and related procedures
  • No financial results or guidance disclosed in this filing

Financial Impact

No financial figures disclosed; compliance issue resolved within one day

Risk Factors

  • Recurring filing delays could indicate ongoing accounting personnel instability
  • Company is exploring strategic alternatives after restructuring, adding uncertainty

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001698530-26-000060
Exhibit: exicure-pressreleasedelaye.htm0001698530-26-000060
Document: 0001698530-26-000060-index-headers.html0001698530-26-000060
Document: 0001698530-26-000060-index.html0001698530-26-000060
Document: 0001698530-26-000060.txt0001698530-26-000060
4 reports for XCUR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XCUR — sortable, filterable
Type Now
Jun 1, 2026
4d ago
Press Release
NEUTRAL ★ 4/10
$3.11 $3.16▲ +1.61%▲ +2.30%$2.92 (−6.11%)
Jun 1, 2026
4d ago
8-K
NEUTRAL ★ 3/10
$3.33 $3.11▼ −6.61%▼ −6.75%$2.92 (−12.31%)
Apr 10, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$3.85 $3.79▼ −1.56%▼ −2.77%$2.92 (−24.12%)
Mar 25, 2026
10w ago
Press Release
BEARISH ★ 8/10
$4.61 $4.42▲ +4.23%▲ +2.55%$2.92 (+36.66%)
Showing 4 of 4

US Market Status

Market Closed — Opens Mon (64h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access